Gregory J. Fluet

Gregory J. Fluet, 44, has served as a director and as Chief Executive Officer of Urologix, Inc., since January 25, 2013. From November 30, 2012 to January 25, 2013, Mr. Fluet served as interim Chief Executive Officer. Prior to that time, he served as Executive Vice President and Chief Operating Officer, since July 14, 2008. Mr. Fluet initially joined Urologix as a consultant in February 2008 to provide strategic analysis and tactical support. Prior to joining Urologix, Mr. Fluet was an associate at Sapient Capital Management, LLC, a venture capital firm focused on early-stage investing in the health care industry, primarily minimally invasive therapeutic medical devices. While at Sapient Capital, he worked with portfolio companies that raised multiple rounds of private financing, completed initial public offerings and were acquired. He was also actively involved in all aspects of early stage medical device company development, including being a board observer, product development, intellectual property development, regulatory analysis, financial modeling, milestone-based budgeting, clinical research and strategic market assessment for portfolio companies or potential investments. Mr. Fluet graduated from Stanford University with a Bachelor of Science in mechanical engineering.